An overview of pregnancy-related issues in patients with multiple sclerosis

European Journal of Neurology

Volumn 22, Issue , 2015, Pages 34-39

  Pozzilli, Carlo ^a   Pugliatti, M ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

Breastfeeding; Multiple sclerosis; Pregnancy; Relapse

Indexed keywords

ALEMTUZUMAB; BETA INTERFERON; DACLIZUMAB; ESTROGEN; FINGOLIMOD; FUMARIC ACID DIMETHYL ESTER; GLATIRAMER; MITOXANTRONE; MONOCLONAL ANTIBODY; NATALIZUMAB; TERIFLUNOMIDE; IMMUNOLOGIC FACTOR;

BREAST FEEDING; DISABILITY; DISEASE COURSE; DRUG CONTRAINDICATION; DRUG SAFETY; FEMALE; FEMALE FERTILITY; FETUS DISEASE; HUMAN; MEDICAL DECISION MAKING; MULTIPLE SCLEROSIS; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; PUERPERIUM; RECURRENCE RISK; REVIEW; COMPLICATION; PREGNANCY COMPLICATIONS; PUERPERAL DISORDERS;

BREAST FEEDING; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MULTIPLE SCLEROSIS; PREGNANCY; PREGNANCY COMPLICATIONS; PUERPERAL DISORDERS;

EID: 84941615492     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12797     Document Type: Review

References (36)

1. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tournaire P, Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 1998; 339: 285-291.
2. Vukusic S, Hutchinson M, Hours M, et al. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 2004; 127: 1353-1360.
3. Finkelsztejn A, Brooks JB, Paschoal FM Jr, Fragoso YD. What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature. BJOG 2011; 118: 790-797.
4. Hughes SE, Spelman T, Gray OM, et al. Predictors and dynamics of postpartum relapses in women with multiple sclerosis. Mult Scler 2014; 20: 739-746.
5. Morales LB, Loo KK, Liu HB, Peterson C, Tiwari-Woodruff S, Vooskuhl RR. Treatment with an estrogen receptor alpha ligand is neuroprotective in experimental autoimmune encephalomyelitis. J Neurosci 2006; 26: 6823-6833.
6. Pozzilli C, De Giglio L, Barletta V, et al. Efficacy and safety of oral contraceptives as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: a multicenter, randomized investigator-run clinical trial [Abstract 171]. Presented at ECTRIMS, 10-13 October 2012; Lyon, France.
7. Sicotte NL, Liva SM, Klutch R, et al. Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol 2002; 52: 421-428.
8. Ponsonby AL, Lucas RM, van der Mei IA, et al. Offspring number, pregnancy, and risk of a first clinical demyelinating event: the AusImmune Study. Neurology 2012; 78: 867-874.
9. Ghezzi A, Caputo D. Pregnancy: a factor influencing the course of multiple sclerosis? Eur Neurol 1981; 20: 115-117.
10. Poser S, Poser W. Multiple sclerosis and gestation. Neurology 1983; 33: 1422-1427.
11. Thompson DS, Nelson LM, Burns A, Burks JS, Franklin GM. The effects of pregnancy in multiple sclerosis: a retrospective study. Neurology 1986; 36: 1097-1099.
12. Weinshenker BG, Hader W, Carriere W, Baskerville J, Ebers GC. The influence of pregnancy on disability from multiple sclerosis: a population-based study in Middlesex County, Ontario. Neurology 1989; 39: 1438-1440.
13. Roullet E, Verdier-Taillefer MH, Amarenco P, Gharbi G, Alperovitch A, Marteau R. Pregnancy and multiple sclerosis: a longitudinal study of 125 remittent patients. J Neurol Neurosurg Psychiatry 1993; 56: 1062-1065.
14. Worthington J, Jones R, Crawford M, Forti A. Pregnancy and multiple sclerosis - a 3-year prospective study. J Neurol 1994; 241: 228-233.
15. Koch M, Uyttenboogaart M, Heersema D, Steen C, De Keyser J. Parity and secondary progression in multiple sclerosis. J Neurol Neurosurg Psychiatry 2009; 80: 676-678.
16. Ramagopalan S, Yee I, Byrnes J, Guimond C, Ebers G, Sadovnick D. Term pregnancies and the clinical characteristics of multiple sclerosis: a population based study. J Neurol Neurosurg Psychiatry 2012; 83: 793-795.
17. Verdru P, Theys P, D'Hooghe MB, Carton H. Pregnancy and multiple sclerosis: the influence on long term disability. Clin Neurol Neurosurg 1994; 96: 38-41.
18. Stenager E, Stenager EN, Jensen K. Effect of pregnancy on the prognosis for multiple sclerosis. A 5-year follow up investigation. Acta Neurol Scand 1994; 90: 305-308.
19. Runmarker B, Andersen O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain 1995; 118: 253-261.
20. D'Hooghe MB, Haentjens P, Nagels G, D'Hooghe T, De Keyser J. Menarche, oral contraceptives, pregnancy and progression of disability in relapsing onset and progressive onset multiple sclerosis. J Neurol 2012; 259: 855-861.
21. Masera S, Cavalla P, Prosperini L, et al. Parity is associated with a longer time to reach irreversible disability milestones in women with multiple sclerosis. Mult Scler 2014; December 22 pii: 1352458514561907. [Epub ahead of print].
22. Karp I, Manganas A, Sylvestre MP, Ho A, Roger E, Duquette P. Does pregnancy alter the long-term course of multiple sclerosis? Ann Epidemiol 2014; 24: 504-508.e2.
23. Jalkanen A, Alanen A, Airas L, Finnish Multiple Sclerosis and Pregnancy Study Group. Pregnancy outcome in women with multiple sclerosis: results from a prospective nationwide study in Finland. Mult Scler 2010; 16: 950-955.
24. Van der Kop ML, Pearce MS, Dahlgren L, et al. Neonatal and delivery outcomes in women with multiple sclerosis. Ann Neurol 2011; 70: 41-50.
25. Dahl J, Myhr KM, Daltveit AK, Hoff JM, Gilhus NE. Pregnancy, delivery, and birth outcome in women with multiple sclerosis. Neurology 2005; 65: 1961-1963.
26. FDA Pregnancy Categories. https://depts.washington.edu/druginfo/Formulary/Pregnancy.pdf (accessed 17/10/2014).
27. Cree BA. Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis. Mult Scler 2013; 19: 835-843.
28. Houtchens MK, Kolb CM. Multiple sclerosis and pregnancy: therapeutic considerations. J Neurol 2013; 260: 1202-1214.
29. Lu E, Wang BW, Guimond C, Synnes A, Sadovnick D, Tremlett H. Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review. Neurology 2012; 79: 1130-1135.
30. Lu E, Wang BW, Guimond C, et al. Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance. Expert Rev Neurother 2013; 13: 251-260; quiz 261.
31. Amato MP, Portaccio E, Ghezzi A, et al. Pregnancy and fetal outcomes after interferon-beta exposure in multiple sclerosis. Neurology 2010; 75: 1794-1802.
32. Giannini M, Portaccio E, Ghezzi A, et al. Pregnancy and fetal outcomes after glatiramer acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study. BMC Neurol 2012; 12: 124.
33. De Giglio L, Gasperini C, Tortorella C, Trojano M, Pozzilli C. Natalizumab discontinuation and disease restart in pregnancy: a case series. Acta Neurol Scand 2015; 131: 336-340 doi: 10.1111/ane.12364. [Epub ahead of print].
34. Coyle PK, Christie S, Fodor P, et al. Multiple sclerosis gender issues: clinical practices of women neurologists. Mult Scler 2004; 10: 582-588.
35. Langer-Gould A, Huang SM, Gupta R, et al. Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis. Arch Neurol 2009; 66: 958-963.
36. Portaccio E, Ghezzi A, Hakiki B, et al. Breastfeeding is not related to postpartum relapses in multiple sclerosis. Neurology 2011; 77: 145-150.